Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy. | Biomedicines | 2022 | 35203494 | PubTator, text mining | PubMed |
| A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity. | Environ Res | 2022 | 35202626 | PubTator, text mining | PubMed |
| ACE inhibitor induced intestinal angioedema. | ANZ J Surg | 2022 | 35199446 | PubTator, text mining | PubMed |
| Integrated Analysis of Multiple Microarrays Based on Raw Data Identified Novel Gene Signatures in Recurrent Implantation Failure. | Front Endocrinol (Lausanne) | 2022 | 35197930 | PubTator, text mining | PubMed |
| A synthetic protein as efficient multitarget regulator against complement over-activation. | Commun Biol | 2022 | 35194132 | PubTator, text mining | PubMed |
| The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk. | EBioMedicine | 2022 | 35183869 | PubTator, text mining | PubMed |
| Clinical Isolates of Acinetobacter spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement System. | Front Immunol | 2022 | 35173727 | PubTator, text mining | PubMed |
| Complement System: An Immunotherapy Target in Colorectal Cancer. | Front Immunol | 2022 | 35173724 | PubTator, text mining | PubMed |
| Zika virus disrupts gene expression in human myoblasts and myotubes: Relationship with susceptibility to infection. | PLoS Negl Trop Dis | 2022 | 35171909 | PubTator, text mining | PubMed |
| Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis. | JCI Insight | 2022 | 35167491 | PubTator, text mining | PubMed |
| An Atypical Case of Idiopathic Nonhistaminergic Angioedema With Anti-C1-INH Antibodies. | J Investig Allergol Clin Immunol | 2022 | 35166675 | PubTator, text mining | PubMed |
| Time-Dependent Molecular Motifs of Pulmonary Fibrogenesis in COVID-19. | Int J Mol Sci | 2022 | 35163504 | PubTator, text mining | PubMed |
| Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm. | Int J Mol Sci | 2022 | 35163216 | PubTator, text mining | PubMed |
| Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor. | World Allergy Organ J | 2022 | 35145604 | PubTator, text mining | PubMed |
| Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. | Alzheimers Res Ther | 2022 | 35139885 | PubTator, text mining | PubMed |
| Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments. | Clin Transplant | 2022 | 35137982 | PubTator, text mining | PubMed |
| The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome. | Brain Pathol | 2022 | 35132719 | PubTator, text mining | PubMed |
| Oral Surgery Procedures in a Patient Affected by Hereditary Angioedema Type I. | Case Rep Dent | 2022 | 35132366 | PubTator, text mining | PubMed |
| A new blood-based RNA signature (R9), for monitoring effectiveness of tuberculosis treatment in a South Indian longitudinal cohort. | iScience | 2022 | 35118358 | PubTator, text mining | PubMed |
| Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids. | iScience | 2022 | 35106453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=56